Form 8-K - Current report:
SEC Accession No. 0001144204-19-020075
Filing Date
2019-04-17
Accepted
2019-04-17 16:03:40
Documents
3
Period of Report
2019-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv519015_8k.htm 8-K 21323
2 EXHIBIT 99.1 tv519015_ex99-1.htm EX-99.1 15271
3 GRAPHIC image_001.gif GRAPHIC 2341
  Complete submission text file 0001144204-19-020075.txt   41062
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 19753091
SIC: 2836 Biological Products, (No Diagnostic Substances)